Clinical context

Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.

What was studied

The authors conducted an overview of reviews on correcting astigmatism with toric IOLs during cataract surgery. MEDLINE, Embase, the Cochrane Library, KSR Evidence and the Trip Database were searched from inception through 2 June 2025. Eighty-five systematic and narrative reviews, meta-analyses and clinical guidelines were included.

How the evidence was produced

A review can assemble clinical context and explain how an approach fits among alternatives. Unlike a randomized trial or formal meta-analysis, it usually does not provide an independent quantitative effect estimate and is more dependent on author selection of the literature. Conclusions should be checked against the cited primary studies and current guidance.

Key result Toric IOLs improved uncorrected distance vision and refractive outcomes in clinically significant astigmatism; the overview also emphasized diagnostics, calculation, alignment and rotational stability.

How to interpret the result

The paper does not compare one specific lens model against another. Instead, it maps the complete clinical pathway, from corneal measurement and cylinder selection to postoperative axis assessment. Its most useful practical message is that refractive accuracy depends not only on toric optics but also on measurement quality, calculation, surgical positioning and lens stability.

The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.

Clinical applicability

This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.

Limitations

This is a narrative overview of reviews and therefore inherits heterogeneity and limitations from the included sources. The authors identify evidence gaps and call for further research in debated areas and diverse clinical settings. It does not establish one cylinder threshold or a universal algorithm for every patient.

Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.

What to verify in the source

In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.